Sparkling CliniTech CareerPath

Are you a seasoned Pharmacovigilance professional with 12–15 years of experience and a passion for AI & automation?

Sparkling CliniTech is inviting ONE dynamic expert as guest speaker for our upcoming Live Webinar + Podcast on
“AI in Pharmacovigilance & Role of Automation.”

🎯 Showcase your expertise in:
AI/ML for ICSR, signal detection, literature screening, QMS
RPA in Argus/Veeva, GAMP 5 CSV
Leading PV automation projects across CROs or pharma firms

🎙️ 1-hour session + live Q&A
🎁 Featured on SparklingCliniTech.com + newsletter
🤝 Co-promotion + guest speaker remuneration

📩 Apply by March 25: DM “AI-PV-GUEST” with your LinkedIn profile, short bio & AI-PV highlights

Interested candidate can contact to:
📧 [email protected]

Let’s spark the future of drug safety together!

🎯 Kickstart Your PV Career with Oracle Argus Safety 8.4.2!
Join our power packed 3-hour workshop that happens every Saturday or Sunday and gain career-ready skills in:

✅ Live Case Processing
✅ MedDRA Coding
✅ E2B (R3) Reporting
✅ Query Resolution
✅ Certification + 30-Day Support
✅ No Hands on Practice but Live Database Demonstration of Every Activity

💥 Launch Offer: ₹4,999 Only
📞 070225 69489 Email:[email protected]
🌐 www.sparklingclintech.com

📢 Limited seats available — Register now and be the spark in global healthcare!

✨ Upgrade Your MedDRA Skills with the Latest Version 29.0! ✨

🚀 Sparkling Clinitech proudly presents an exclusive MedDRA Version 29.0 Training Opportunity designed for aspiring and working pharmacovigilance professionals!

📚 What You’ll Get:
✅ Complete One Month Hands-On Practice with MedDRA 29.0
✅ Practical exposure to the latest MedDRA release
✅ Regular Live Classes with expert guidance
✅ Structured Preparation for MedDRA Certification Exam
✅ Real-time case studies & interactive sessions
✅ Essential skills to boost your PV career

🎯 Whether you're a fresher or an experienced professional, this program will help you stay updated and competitive in the global healthcare industry.

⏳ Limited Slots Available – Enroll Today!

📞 Call/WhatsApp: +91-7022569489
📧 Email: [email protected]

🌐 Visit: www.sparklingclinitech.com

💡 Be the Spark in Global Healthcare with Sparkling Clinitech!

.0

Exciting news from Sparkling CliniTech! We've just earned the official Certificate of Attendance from the MedDRA Maintenance and Support Services Organization (MSSO) for completing the "What's New with MedDRA V29.0 and the MSSO" webinar on February 26, 2026.
​
​Certificate Highlights
This 60-minute session covered key updates in MedDRA 29.0, released March 1, 2026, including hierarchy changes like new HLTs for polio virus infections, medication error term movements, and SMQ strategies.
​
Training Opportunity
Starting March 2, 2026 (note: query date adjusted to current year for timeliness), join Sparkling CliniTech's hands-on MedDRA 29.0 training to master the latest version—covering hierarchy updates, coding drills, SMQs, and exam prep for pharmacovigilance pros.

Enroll now via WhatsApp at +91 7022569489 or visit sparklingclinitech.com for schedules and certification. Don't miss sparkling your PV career with the newest release!

Latest Drug Safety Alert from CDSCO for seniors:

The most recent drug safety alerts relevant to elderly patients include warnings on doxycycline and carbimazole from India's CDSCO in February 2026.

India's Central Drugs Standard Control Organisation issued fresh safety updates following a national pharmacovigilance review. Doxycycline, a common antibiotic for infections in older adults, now carries warnings for mental health side effects like restlessness, anxiety, irritability, nervousness, and dizziness.

Carbimazole, used for thyroid issues prevalent in the elderly, highlights a rare but serious risk of life-threatening blood disorders.

Source:

Thyroid, infection drugs get fresh safety warnings after national review | India News - The Times of India India News: NEW DELHI: Two medicines used widely - antibiotic doxycycline and thyroid drug carbimazole - will soon carry stronger safety warnings, following a nat.